Regeneron Pharmaceuticals raises dividend by 6.8% to $0.94 [Seeking Alpha]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Seeking Alpha
Payable March 5; for shareholders of record Feb. 20; ex-div Feb. 20. See REGN Dividend Scorecard, Yield Chart, & Dividend Growth. More on Regeneron Pharmaceuticals Regeneron: Expect Double-Digit Growth In 2026 Regeneron Pharmaceuticals, Inc. (REGN) Q4 2025 Earnings Call Transcript Regeneron Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation Regeneron outlines 18 new Phase III studies and expects four FDA approvals in 2026 while advancing EYLEA HD and DUPIXENT growth Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at JPMorgan Chase & Co. from $850.00 to $950.00. They now have an "overweight" rating on the stock.MarketBeat
- Regeneron 2026 Outlook Balanced With Dupixent Growth, Sanofi Collaboration, RBC Says [Yahoo! Finance]Yahoo! Finance
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $865.00 price target on the stock, up previously from $750.00.MarketBeat
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at Morgan Stanley from $768.00 to $769.00. They now have an "equal weight" rating on the stock.MarketBeat
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at Wells Fargo & Company from $745.00 to $800.00. They now have an "equal weight" rating on the stock.MarketBeat
REGN
Earnings
- 1/30/26 - Beat
REGN
Sec Filings
- 2/4/26 - Form 10-K
- 1/30/26 - Form 8-K
- 1/12/26 - Form 8-K
- REGN's page on the SEC website